Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Parkinson's Disease

  Free Subscription


02.03.2026

2 Ann Neurol
1 BMC Neurol
1 Brain Res
2 Exp Neurol
1 J Neural Transm (Vienna)
1 Lancet
4 Mov Disord
1 Nature
1 Neurobiol Dis
1 Neurochem Res
2 Neurology
1 Neurosci Lett
3 Neuroscience
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Neurol

  1. LUTH T, Laabs BH, Sendel S, Konig IR, et al
    The Age at Onset of LRRK2 p.Gly2019Ser Parkinson's Disease Across Ancestries and Countries of Origin.
    Ann Neurol. 2026 Feb 24. doi: 10.1002/ana.78181.
    PubMed         Abstract available

  2. HACH A, Lohmann K, Funayama M, Menon PJ, et al
    Alternative Translation Initiation in PRKN Delays the Onset of Parkinson's Disease and Offers a Therapeutic Target.
    Ann Neurol. 2026 Feb 22. doi: 10.1002/ana.78180.
    PubMed         Abstract available


    BMC Neurol

  3. RYU HJ, Seo JP, Park SY
    Comprehensive diffusion tensor tractography of three dopaminergic pathways in advanced Parkinson's disease: a case report.
    BMC Neurol. 2026 Feb 26. doi: 10.1186/s12883-026-04757.
    PubMed        


    Brain Res

  4. FENG H, Zhuang P, Zhang Y, Li J, et al
    Patterns of subthalamic synchronized oscillatory neurons are characteristics of motor subtypes of Parkinson's disease.
    Brain Res. 2026;1880:150224.
    PubMed         Abstract available


    Exp Neurol

  5. QUAN Z, Ku CY, Xie T, Fok HT, et al
    Mitochondrial dysfunction and disrupted neuronal lipid homeostasis in Parkinson's disease: Potential mechanisms and therapeutic implications.
    Exp Neurol. 2026 Feb 25:115703. doi: 10.1016/j.expneurol.2026.115703.
    PubMed         Abstract available

  6. DAS A, Das R, Das A, Aich P, et al
    Microbiome- metabolome signatures and Behavioral alterations in a progressive MPTP-induced mouse model of Parkinson's disease.
    Exp Neurol. 2026;400:115701.
    PubMed         Abstract available


    J Neural Transm (Vienna)

  7. PRASAD S, Bhardwaj M, Nagaraj T, Bhat SGS, et al
    Differential psychosocial burden in parkinson's disease: a gender-based comparison.
    J Neural Transm (Vienna). 2026 Feb 25. doi: 10.1007/s00702-026-03120.
    PubMed        


    Lancet

  8. DE NEELING MGJ, Keulen BJ, Stam MJ, van Wijk BCM, et al
    Adaptive deep brain stimulation in Parkinson's disease.
    Lancet. 2026 Feb 18:S0140-6736(25)02274-3. doi: 10.1016/S0140-6736(25)02274.
    PubMed         Abstract available


    Mov Disord

  9. ZHANG Y, Chen Y, Kang Y, Chen X, et al
    Novel Variants in DCTN1 Associated with Perry Disease: A Case Series from a Chinese Parkinsonism Cohort.
    Mov Disord. 2026 Feb 22. doi: 10.1002/mds.70244.
    PubMed         Abstract available

  10. PAPAGIANNAKIS N, Koros C, Simitsi AM, Stefanis L, et al
    Increased Serum Neurofilament Light Chain Levels in Parkinson's Disease Patients Carrying the p.A53T SNCA Mutation: Data from the Parkinson's Progression Markers Initiative Study.
    Mov Disord. 2026 Feb 23. doi: 10.1002/mds.70236.
    PubMed         Abstract available

  11. TOFFOLI M, Menozzi E, Chowdhury K, Foltynie T, et al
    Ambroxol for Parkinson's Disease.
    Mov Disord. 2026 Feb 24. doi: 10.1002/mds.70242.
    PubMed        

  12. TIAN Y, Matar E, Berkovsky S, Lewis SJG, et al
    Aberrant Beta-Band Network Alteration Preceding Freezing of Gait in Parkinson's Disease.
    Mov Disord. 2026 Feb 27. doi: 10.1002/mds.70230.
    PubMed         Abstract available


    Nature


  13. Parkinson's disease affects network of brain regions that controls whole-body action.
    Nature. 2026 Feb 25. doi: 10.1038/d41586-026-00573.
    PubMed        


    Neurobiol Dis

  14. CHENG B, Cheng S, Wei W, Pan C, et al
    Residential green space, natural environment, domestic garden, and the risk of Parkinson's disease: A prospective cohort study.
    Neurobiol Dis. 2026 Feb 25:107334. doi: 10.1016/j.nbd.2026.107334.
    PubMed         Abstract available


    Neurochem Res

  15. ROUT M, Prusty SK, Singh V, Kispotta S, et al
    Targeting the Microbiota-Gut-Brain Axis: Bacillus coagulans Protects Against Rotenone-Induced Parkinson's Disease in Rats.
    Neurochem Res. 2026;51:86.
    PubMed         Abstract available


    Neurology

  16. AHN SH, Kim DH, Park J, Yoon J, et al
    Dynamic Smoking Patterns and Risk of Parkinson Disease and All-Cause Mortality: A Competing Risk Analysis Approach.
    Neurology. 2026;106:e214722.
    PubMed         Abstract available

  17. URSO D, Logroscino G
    Dynamic Smoking Patterns and Risk of Parkinson Disease.
    Neurology. 2026;106:e214651.
    PubMed        


    Neurosci Lett

  18. LI Z, Chen Z, Duan Z, Liu Y, et al
    Inhibition of Death-Associated Protein Kinase 1 ameliorates central and peripheral pathological changes in a mouse model of Parkinson's disease.
    Neurosci Lett. 2026;876:138546.
    PubMed         Abstract available


    Neuroscience

  19. HU ZX, He YZ, Huang X, Wen Z, et al
    Integrative analysis of spontaneous brain activity in Parkinson's disease: associations with gene expression, cell types, and receptor density.
    Neuroscience. 2026 Feb 25:S0306-4522(26)00146.
    PubMed         Abstract available

  20. REN B, Yan H, Han C, Sun S, et al
    How cytochrome P450 enzymes in humans are involved in Parkinson's disease: a literature review.
    Neuroscience. 2026 Feb 21:S0306-4522(26)00139.
    PubMed         Abstract available

  21. PANDA SP, Saraswat N, Singh V
    Gene therapy targeting synaptopathy linked with Alzheimer's and Parkinson's disease.
    Neuroscience. 2026 Feb 21:S0306-4522(26)00138.
    PubMed         Abstract available


    PLoS One

  22. LATELLA D, Lombardo Facciale A, Bonanno M, Bonanno L, et al
    Enhancing gait training with anti-gravity treadmill 'Alter-G' in patients with Parkinson's disease.
    PLoS One. 2026;21:e0341021.
    PubMed         Abstract available

  23. MUHAMMAD J, Ghergherehchi M, Ali S, Seung Song H, et al
    Trustworthy AI for medical decisions: Adversarially robust and fair machine learning prediction for Parkinson's disease.
    PLoS One. 2026;21:e0342062.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum